Congressional Trader
Live

PCVX congressional trades

5 matched disclosures

Track congressional trades for PCVX
Tracked disclosures
5
Lawmakers
2
Buy / sell
4 / 1
Avg post-trade move
N/A
Latest filing 2026-06-08

PCVX congressional trades snapshot

This page summarizes public STOCK Act disclosures involving PCVX. It is useful for seeing which lawmakers reported PCVX transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.

Last updated

Jun 8, 2026

Data source

Public House and Senate STOCK Act disclosures normalized by Congressional Trader.

Key caveat

Filing date can trail transaction date. This page is for research and monitoring, not investment advice.

What the PCVX congressional trade page shows

Congressional Trader tracks 5 public STOCK Act disclosures for PCVXacross 2 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.

The most recent PCVX filing shown here was filed on Jun 8, 2026 by Gilbert Ray Cisneros as a purchase. Related lawmakers include Gilbert Ray Cisneros, Jefferson Shreve.

Pro performance summary

Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.

Compare Pro plans
No committee data
Filed Jun 8, 2026
Delay 26 days
View filing
PCVXNotable
Vaxcyte, Inc. - Common Stock
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Jun 8, 2026
Delay 27 days
View filing
PCVXNotable
Vaxcyte, Inc. - Common Stock
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed May 6, 2025
Delay 8 days
View filing
Vaxcyte, Inc. - Common Stock
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed May 6, 2025
Delay 21 days
View filing
Vaxcyte, Inc. - Common Stock
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Apr 11, 2025
Delay 37 days
View filing
Vaxcyte, Inc. - Common Stock
Sale
$15K - $50K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade

FAQ

Which lawmakers traded PCVX?

Recent PCVX disclosures include Gilbert Ray Cisneros, Jefferson Shreve.

What is the buy/sell mix for PCVX?

The visible sample currently shows 4 purchases and 1 sales or partial sales.

Should I trade based on PCVX disclosures?

No. This page summarizes public filings for research and monitoring. It is not investment advice.